The CD95(APO-1/Fas) DISC and beyond

Cell Death and Differentiation

Volumn 10, Issue 1, 2003, Pages 26-35

  Peter, M E ^a   Krammer, P H ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b Tumorimmunology Program   (Germany)

Author keywords

Apoptosis; DISC; TNF

Indexed keywords

ADAPTOR PROTEIN; CASPASE; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR;

AMINO ACID SEQUENCE; APOPTOSIS; CELL DEATH; CELL TYPE; COMPLEX FORMATION; CYTOPLASM; ENZYME ACTIVATION; ENZYME REGULATION; GENE DELETION; GENE MUTATION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASES; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; EUKARYOTIC CELLS; HUMANS; MACROMOLECULAR SUBSTANCES; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 0037276437     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401186     Document Type: Review

References (122)

1. Vogt C (1842) Untersuchungen über die Entwicklungsgeschichte der Geburtshelferkröte (Alyles obstetricans). Jent & Gassmann, Solothurn
2. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S and Peter ME (1998) Apoptosis signaling by death receptors. Eur. J. Biochem. 254: 439-459
3. Papoff G, Hausler P, Eramo A, Pagano MG, Di Leve G, Signore A and Ruberti G (1999) Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor. J. Biol. Chem. 274: 38241-38250
4. Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, Lynch D, Tsien RY and Lenardo MJ (2000) Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288: 2354-2357
5. Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL and Lenardo MJ (2000) A domain in TNF receptors that mediates ligand independent receptor assembly and signaling. Science. 288: 2351-2354
6. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH and Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14: 5579-5588
7. Siegel RM, Chan FK, Chun HJ and Lenardo MJ (2000) The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 1: 469-474
8. Peter ME, Scaffidi C, Medema JP, Kischkel F and Krammer PH (1999) The death receptors. Results Probl. Cell. Differ. 23: 25-63
9. Chinnaiyan AM, Tepper C, Lou L, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME and Dixit VM (1996) FADD/MORT1 is a common mediator of Fas/APO-1- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 271: 4961-4965
10. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827
11. Boldin MP, Goncharov TM, Goltsev YV and Wallach D (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85: 803-815
12. Earnshaw WC, Martins LM and Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68: 383-424
13. Scaffidi C, Medema JP, Krammer PH and Peter ME (1997) FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J. Biol. Chem. 272: 26953-26958
14. Stegh AH, Herrmann H, Lampel S, Weisenberger D, Andra K, Seper M, Wiche G, Krammer PH and Peter ME (2000) Identification of the cytolinker plectin as a major early in vivo substrate for caspase-8 during CD95 and TNF-receptor mediated apoptosis. Mol. Cell. Biol. 20: 5665-5679
15. L expressing MCF7-Fas cells: role for the BAR protein. J. Biol. Chem. 277: 4351-4360
16. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH and Peter ME (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16: 2794-2804
17. Salvesen GS and Dixit VM (1999) Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA 96: 10964-10967
18. Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P, Gazdar A, Blenis J, Arnott D and Ashkenazi A (2001) Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J. Biol. Chem. 276: 46639-46646
19. Wang J, Chun HJ, Wong W, Spencer DM and Lenardo MJ (2001) Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl. Acad. Sci. USA. 98: 13884-13888
20. Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA and Walczak H (2002). Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but cannot functionally substitute caspase-8. EMBO J. 21: 4520-4530
21. L is a dual function regulator for caspase-8 activation and CD95 (APO-1/Fas-mediated apoptosis. EMBO J. 21: 3704-3714
22. Wang J, Zheng L, Lobito A, Chan FK, Dale J, Sneller M, Yao X, Puck JM, Straus SE and Lenardo MJ (1999) Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98: 47-58
23. Hu S, Vincenz C, Buller M and Dixit VM (1997) A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272: 9621-9624
24. Bertin J, Armstrong RC, Ottilie S, Martin DA, Wang Y, Banks S, Wang GH, Senkevich TG Alnemri ES, Moss B, Lenardo MJ, Tomaselli KJ and Cohen JI (1997). Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94: 1172-1176
25. Thome M, Schneider P, Hofmann K, Fickenscher H, Meini E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME and Tschopp J (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386: 517-521
26. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE and Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195
27. Shu HB, Halpin DR and Goeddel DV (1997) Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6: 751-763
28. Srinivasula SM, Ahmad M, Ottilie S, Bullrich F, Banks S, Wang Y, Fernandes-Alnemri T, Croce CM, Litwack G, Tomaselli KJ, Armstrong RC and Alnemri ES (1997) FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 272: 18542-18545
29. Inohara N, Koseki T, Hu Y, Chen S and Nunez G (1997) CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc. Natl. Acad. Sci. USA 94: 10717-10722
30. Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM and Wallach D (1997) CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272: 19641-19644
31. Han DK, Chaudhary PM, Wright ME, Friedman C, Trask BJ, Riedel RT, Baskin DG, Schwartz SM and Hood L (1997) MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. Proc. Natl. Acad. Sci. USA 94: 11333-11338
32. Hu S, Vincenz C, Ni J, Gentz R and Dixit VM (1997) I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J. Biol. Chem. 272: 17255-17257
33. Rasper DM, Vaillancourt JP, Hadano S, Houtzager VM, Seiden I, Keen SL, Tawa P, Xanthoudakis S, Nasir J, Martindale D, Koop BF, Peterson EP, Thornberry NA, Huang J, MacPherson DP, Black SC, Hornung F, Lenardo MJ, Hayden MR, Roy S and Nicholson DW (1998) Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ. 5: 271-288
34. Scaffidi C, Schmitz I, Krammer PH and Peter ME (1999) The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274: 1541-1548
35. Krueger A, Schmitz I, Baumann S, Krammer PH and Kirchhoff S (2001) Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 276: 20633-20640
36. Refaeli Y, Van Parijs L, London CA, Tschopp J and Abbas AK (1998) Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8: 615-623
37. Algeciras-Schimnich A, Griffith TS, Lynch DH and Paya CV (1999) Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J. Immunol. 162: 5205-5211
38. Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A, Mirtsos C, Suzuki N, Bonnard M, Goeddel DV and Mak TW (2000) Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12: 633-642
39. Hu WH, Johnson H and Shu HB (2000) Activation of NF-kappaB by FADD, Casper, and caspase-8. J. Biol. Chem. 275, 10838-10844
40. Chaudhary PM, Jasmin A, Eby MT and Hood L (1999) Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 18, 5738-5746
41. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M and Tschopp J (2000) The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr. Biol. 10: 640-648
42. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV and Boldin MP (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17: 331-367
43. Yang X, Khosravi-Far R, Chang HY and Baltimore D (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89, 1067-1076
44. Torii S, Egan DA, Evans RA and Reed JC (1999) Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J. 18: 6037-6049
45. Li H, Leo C, Zhu J, Wu X, O'Neil J, Park EJ and Chen JD (2000) Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol. Cell. Biol. 20: 1784-1796
46. Zhong S, Salomoni P, Ronchetti S, Guo A, Ruggero D and Pandolfi PP (2000) Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. J. Exp. Med. 191: 631-640
47. Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R and Pandolfi PP (1998) PML is essential for multiple apoptotic pathways. Nat. Genet. 20: 266-272
48. Michaelson JS, Bader D, Kuo F, Kozak C and Leder P (1999) Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development. Genes Dev. 13: 1918-1923
49. Michaelson JS (2000) The Daxx engima. Apoptosis 5: 217-220
50. Sato T, Irie S, Kitada S and Reed JC (1995) FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268: 411-415
51. Li Y, Kanki H, Hachiya T, Ohyama T, Irie S, Tang G, Mukai J and Sato T (2000) Negative regulation of Fas-mediated apoptosis by FAP-1 in human cancer cells. Int. J. Cancer. 87: 473-479
52. Zhou YW, Komada Y, Inaba H, Azuma E and Sakurai M (1998) Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells. Cell. Immunol. 186: 103-110
53. Yanagisawa J, Takahashi M, Kanki H, Yano-Yanagisawa H, Tazunoki T, Sawa E, Nishitoba T, Kamishohara M, Kobayashi E, Kataoka S and Sato T (1997) The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J. Biol. Chem. 272: 8539-8545
54. Imai Y, Kimura T, Murakami A, Yajima N, Sakamaki K and Yonehara S (1999) The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature 398: 777-785
55. Koonin EV, Aravind L, Hofmann K, Tschopp J and Dixit VM (1999) Apoptosis. Searching for FLASH domains. Nature 401: 662-663
56. Stanger BZ, Leder P, Lee TH, Kim E and Seed B (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81: 513-523
57. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B and Tschopp J (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1: 489-495
58. Chu K, Niu X and Williams, LT (1995) A Fa-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc. Natl. Acad. Sci. 92: 11894-11898
59. Kissil JL, Cohen O, Raveh T and Kimchi A (1999) Structure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-alpha- and Fas-induced cell death. EMBO J. 18: 353-362
60. Berger T and Kretzler M (2002) Interaction of DAP3 and FADD only after cellular disruption. Nat. Immunol. 3: 3-5
61. Suzuki T, Terasaki M, Takemoto-Hori C, Hanada T, Ueda T, Wada A and Watanabe K (2001). Proteomic analysis of the mammalian mitochondrial ribosome. Identification of protein components in the 28 S small subunit. J. Biol. Chem. 276: 33181-33195
62. Yang X, Chang HY and Baltimore D (1998) Autoproteolytic activation of pro-caspases by oligomerization. Mol. Cell. 1: 319-325
63. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS and Dixit VM (1998) An induced proximity model for caspase-8 activation. J. Biol. Chem. 273: 2926-2930
64. Martin DA, Siegel RM, Zheng L and Lenardo MJ (1998) Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal. J. Biol. Chem. 273: 4345-4349
65. Renatus M, Stennicke HR, Scott FL, Liddington RC and Salvesen GS (2001) Dimer formation drives the activation of the cell death protease caspase 9. Proc. Natl. Acad. Sci. USA 98: 14250-14255
66. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW and Thornberry NA (1998) Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273: 32608-32613
67. Kirchhoff S, Muller WW, Krueger A, Schmitz I and Krammer PH (2000) TCR-mediated up-regulation of c-FLIPshort correlates, with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J. Immunol. 165: 6293-6300
68. Kirchhoff S, Muller WW, Li-Weber M and Krammer PH (2000) Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells. Eur. J. Immunol. 30: 2765-2774
69. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675-1687
70. Li H, Zhu H, Xu CJ and Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501
71. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490
72. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ and Schlesinger PH (2000) Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ. 7: 1166-1173
73. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489
74. Yin X-M, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, Roth KA and Korsmeyer SJ (1999) Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400: 886-891
75. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, Ulrich E, Waymire KG, Mahar P, Frauwirth K, Chen Y, Wei M, Eng VM, Adelman DM, Simon MC, Ma A, Golden JA, Evan G, Korsmeyer SJ, MacGregor GR and Thompson CB (2000) The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6: 1389-1399.
76. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730
77. Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, Joulin V and Kahn A (1996) Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 2: 80-86
78. Rodriguez I, Matsuura K, Khatib K, Reed JC, Nagata S and Vassalli P (1996) A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J. Exp. Med. 83: 1031-1036
79. Strasser A, Harris AW, Huang DC, Krammer PH and Cory S (1995) Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14: 6136-6147
80. Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM and Salvesen GS (1997) Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J. Biol. Chem. 272: 7797-7800
81. Tollefson AE, Hermiston TW, Lichtenstein DL, Colle CF, Tripp RA, Dimitrov T, Toth K, Wells CE, Doherty PC and Wold WS (1998) Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392: 726-730
82. Elsing A and Burgert HG (1998) The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc. Natl. Acad. Sci. USA 95: 10072-10077
83. Toker A (1998) Signaling through protein kinase C. Front. Biosci. 3: D1134-D1147
84. Copeland KF, Haaksma AG, Goudsmit J, Krammer PH and Heeney JL (1994) Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res. Hum. Retroviruses 10: 1259-1268
85. Cuvillier O, Rosenthal DS, Smulson ME and Spiegel S (1998) Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes. J. Biol. Chem. 273: 2910-2916
86. Rudert F, Wang Y, Lindridge E and Watson J (1997) Apoptosis through CD95(Fas/APO-1), but not a CD40/CD95 chimeric receptor, is inhibited by phorbol-12-myristate-13-acetate. DNA Cell Biol. 16: 197-205
87. Drew L, Kumar D, Bandyopadhyay D and Gupta S (1998) Inhibition of the protein kinase C pathway promotes anti-CD95-induced apoptosis in Jurkat T cells. Int. Immunol. 10: 877-889
88. Zhou T, Song L, Yang P, Wang Z, Lui D and Jope RS (1999) Bisindolylmalmeide VIII facilitates Fa-mediated apoptosis and inhibits T cell-mediated autoimmune diseases. Nat. Med. 5: 42-48
89. Chen CY and Faller DV (1999) Selective inhibition of protein kinase C isozymes by Fas ligation. J. Biol. Chem. 274: 15320-15328
90. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH and Peter ME (1999) Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274: 22532-22538
91. Tan Y, Ruan H, Demeter MR and Comb MJ (1999) p90(RSK) blocks bad-mediated cell death via a protein kinase C-dependent pathway. J. Biol. Chem. 274: 34859-34867
92. Ruiz-Ruiz C, Robledo G, Font J, Izquierdo M and Lopez-Rivas A (1999) Protein kinase C inhibits CD95 (Fas/APO-1)-mediated apoptosis by at least two different mechanisms in Jurkat T cells. J. Immunol. 163: 4737-4746
93. Meng XW, Heldebrant MP and Kaufmann SH (2002) Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain. J. Biol. Chem. 277: 3776-3783
94. Gomez-Angelats M and Cidlowski JA (2001) Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis. J. Biol. Chem. 276: 44944-44952
95. Eischen CM, Dick CJ and Leibson PJ (1994) Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 152: 1947-1954
96. Atkinson EA, Ostergaard H, Kane K, Pinkoski MJ, Caputo A, Olszowy MW and Bleackley RC (1996). A physical interaction between the cell death protein Fas and the tyrosine kinase p59fynT. J. Biol. Chem. 271: 5968-5671
97. Schraven B and Peter ME (1995) APO-1 (CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45. FEBS Lett. 368: 491-494
98. Uckun FM (1998) Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosis. Biochem. Pharmacol. 56: 683-691
99. Vassilev A, Ozer Z, Navara C, Mahajan S and Uckun FM (1999) Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex. J. Biol. Chem. 274: 1646-1656
100. Daigle I, Yousefi S, Colonna M, Green DR and Simon HU (2002) Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic sgnaling in neutrophils. Nat. Med. 8: 61-67
101. Beltinger C, Fulda S, Kammertoens T, Meyer E, Uckert W and Debatin KM (1999) Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc. Natl. Acad. Sci. USA 96: 8699-8704
102. Aragane Y, Kulms D, Metze D, Wilkes G, Poppelmann B, Luger TA and Schwarz T (1998) Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J. Cell. Biol. 140: 171-182
103. Hennino A, Bérard M, Krammer PH and Defrance T (2001) FLICE-inhibitory protein is a key regulator of germinal center B cell apoptosis. J. Exp. Med. 193: 447-458
104. Cremesti A, Paris F, Grassme H, Holler N, Tschopp J, Fuks Z, Gulbins E and Kolesnick R (2001) Ceramide enables fas to cap and kill. J. Biol. Chem. 276: 23954-23961
105. Grassme H, Jekle A, Riehle Schwarz H, Berger J, Sandhoff K, Kolesnick R and Gulbins E (2001) CD95 signaling via ceramide-rich membrane rafts. J. Biol. Chem. 276: 20589-20596
106. Algeciras-Schimnich A, Shen L, Barnhart BC, Murmann AE, Burkhardt JK and Peter ME (2002) Molecular ordering of the initial signaling events of CD95. Mol. Cell. Biol. 22: 207-220
107. Hueber AO, Bernard AM, Herincs Z, Couzinet A and He HT (2002) An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes. EMBO Rep. 3: 190-196
108. Legembre P, Moreau P, Daburon S, Moreau JF and Taupin JL (2002) Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas. Cell Death Differ. 9: 329-339
109. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F and Lynch DH (1993) Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178: 2231-2235
110. Newton K, Harris AW, Bath ML, Smith KG and Strasser A (1998) A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17: 706-718
111. Zhang J, Cado D, Chen A, Kabra NH and Winoto A (1998) Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392: 296-300
112. O'Reilly LA, Huang DC and Strasser A (1996) The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15: 6979-6990
113. Kennedy NJ, Kataoka T, Tschopp J and Budd RC (1999) Caspase activation is required for T cell proliferation. J. Exp. Med. 190: 1891-1896
114. Alam A, Cohen LY, Aouad S and Sekaly RP (1999) Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190: 1879-1890
115. Zhou BB, Li H, Yuan J and Kirschner MW (1998) Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells. Proc. Natl. Acad. Sci. USA 95: 6785-6790
116. Inaba M, Kurasawa K, Mamura M, Kumano, K, Saito Y and Iwamoto I (1999) Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells. J. Immunol. 163: 1315-1320
117. Dao T, Huleatt JW and Hingorani R (1997) Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle. J. Immunol. 159: 4261-4267
118. Karas M, Zaks TZ, Liu JL and LeRoith D (1999) T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle. Mol. Biol. Cell. 10: 4441-4450
119. Parlato S, Giammarioli AM, Logozzi M, Lozupone F, Matarrese P, Luciani F, Falchi M, Malorni W and Fais S (2000) CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 19: 5123-5134
120. Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei CF, Chang HM and Yeh ET (1996) Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J. Immunol. 157: 4277-4281
121. Wright DA, Futcher B, Ghosh P and Geha RS (1996) Association of human fas (CD95) with a ubiquitin-conjugating enzyme (UBC-FAP). J. Biol. Chem. 271: 31037-31043
122. Becker K, Schneider P, Hofmann K, Mattmann C and Tschopp J (1997) Interaction of Fas(Apo-1/CD95) with proteins implicated in the ubiquitination pathway. FEBS Lett. 412: 102-106